StockData
Jupiter Neurosciences, Inc. logo

Jupiter Neurosciences, Inc. (JUNS) stock

JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$1.52+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.17MP/E –Yield –

Jupiter Neurosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $21.80K.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.80K–
FY2024Dec 31, 2024$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$24.25K–
Q1 FY2026Mar 31, 2026$18.65K–
Q1 FY2025Mar 31, 2025$0–

More Jupiter Neurosciences figures

See a number that looks wrong?